SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2344thanks to both of you....bob zagorin-3/10/2005
2343The EVEREST trial has nothing to do with the current sNDA. It is done to increasboronate-3/10/2005
2342You were referring to the second-line sNDA? No, I don't think there is any cIcebrg-3/10/2005
2341i'm just wondering whether the announcement of the everest trial means fda abob zagorin-3/10/2005
2340Sooner than what?Icebrg-3/10/2005
2339question. could the everest trial be a prerequisite for FDA approval sooner rathbob zagorin-3/10/2005
2338Velcade(R) (bortezomib) for Injection Multiple Myeloma Retreatment Clinical Triabob zagorin-3/10/2005
2337Hello Miljenko, Have you got anything good to recommend below $5? The REGENERON kokoroko-3/9/2005
2336Velcade against Dex versus Revlimid + Dex against Dex!Miljenko Zuanic-3/9/2005
2335Miljenko Please explain <apples to potatoes>.winbiggs-3/9/2005
2334Regulatory Roadblocks Ahead for Celgene Scott Gottlieb, M.D., 03.08.05, 6:10 PM Icebrg-3/9/2005
2333Love when analysts in their "analysis" compare apples to potatoes. ConMiljenko Zuanic-3/8/2005
233210k... xml.10kwizard.combob zagorin-3/8/2005
2331Data Support the Positive Clinical Benefits of GP IIb-IIIa Inhibitors and INTEGRbob zagorin-3/8/2005
2330>>BALTIMORE, March 8 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Intuck-3/8/2005
2329Millennium Achieves Milestone Payments of Approximately $40 Million -- INTEGRILIbob zagorin-3/7/2005
2328<i>citing a lack of investor interest.</i> Presumably in the loan pnigel bates-3/4/2005
2327First time I've seen Investor Apathy cited as a reason for an analyst ratingIan@SI-3/4/2005
2326It was gauged soley on liver enzyme elevation, which occurred after each dosing boronate-3/4/2005
2325Thanks, I knew I'd seen it somewhere, and bells rang with the "CT"tuck-3/3/2005
2324>>Wonder who owns CT-32615?>> CTIC cancerres.aacrjournals.org EriIcebrg-3/3/2005
2323[Bortezomib-Induced Severe Hepatitis in Multiple Myeloma: A Case Report] >&gtuck-3/3/2005
2322 >>Oncogene. 2005 Feb 21; [Epub ahead of print] Molecular characterizattuck-3/3/2005
2321[Velcade & liposomal anthracyclines in the treatment of MM] >>Semin Otuck-2/20/2005
2320Part 4: <b>VELCADE in combination with prednisone in patients with advancIan@SI-2/20/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News